NL-OMON25987尚未招募不适用
Carfilzomib in combination with Thalidomide and Dexamethasone for remission induction and consolidation of Multiple Myeloma at first presentation.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- Erasmus MC
- 入组人数
- 145
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with a confirmed diagnosis of multiple myeloma stage I to III according to the ISS criteria;
- •2. Age 18-65 years inclusive;
排除标准
- •1. Known intolerance of Thalidomide;
- •2. Systemic AL amyloidosis;
研究者
相似试验
进行中（未招募）
1 期
Carfilzomib in combination with Thalidomide and Dexamethasone for remission induction and consolidation of Multiple Myeloma at first presentatioMultiple myeloma at first presentationEUCTR2009-014922-40-NLErasmus MC
已完成
2 期
Carfilzomib in combination with Thalidomide and Dexamethasone for remission induction and consolidation of Multiple Myeloma at first presentatio10027656Multiple MyelomaNL-OMON46962Erasmus MC, Universitair Medisch Centrum Rotterdam145
进行中（未招募）
1 期
Carfilzomib + Lenalidomide +Dexamethasone for BTK inhibitors relapsed-refractory or intolerant mantle cell lymphomasBTK inhibitors relapsed-refractory or intolerant mantle cell lymphomasMedDRA version: 20.0Level: PTClassification code 10061275Term: Mantle cell lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000540-25-ITFONDAZIONE ITALIANA LINFOMI ONLUS59
进行中（未招募）
1 期
se of a novel chemotherapeutic regimen in an attempt to eradicate residual myeloma disease after a first autologous stem cell Transplantation.MedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2016-004778-16-ATDepartment of Medicine I, Ordensklinikum Linz, Elisabethinen Hospital Linz41
进行中（未招募）
1 期
Pomalidomide combined with Carfilzomib and Dexamethasone (PCd) forinduction and consolidation followed by Pomalidomide combined withDexamethason vs Pomalidomide maintenance for patients with MultipleMyeloma in progression after prior 1st line treatment with Lenalidomideand Bortezomib.MedDRA version: 19.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2013-003265-34-CZStichting Hemato-Oncologie voor Volwassenen Nederland (Hovon)222